947
Participants
Start Date
September 30, 2004
Study Completion Date
October 31, 2005
Otamixaban (XRP0673)
Unfractionated Heparin
Percutaneous Coronary Intervention
University Hospital Hradec Kralove, Hradec Králové
Cliniques Universitaires Saint-Luc, Brussels
UZ Gasthuisberg, Leuven
Kuils River Private Hospital, Kuils River
Milton S. Hershey Medical Center, Hershey
University of Pennsylvania Health System, Philadelphia
George Washington University Medical Faculty Associates, Washington D.C.
Gamelinschalftspraxis, Hamburg
Center Hospitalier Universitaire Jean-Minjoz, Besançon
LeBauer Cardiovascular Research Foundation, Greensboro
Wake Heart Associates, Raleigh
Hospital Clinico San Carlos, Madrid
Hospital Gregorio Maranon, Madrid
Hospital Virgen de la Victoria, Málaga
Columbia Heart Clinic, Columbia
Clinique Les Franciscaines, Nîmes
Cardiac Disease Specialists, Atlanta
Emory University Hospital, Atlanta
Cardiology Associates, PA, Panama City
Central Florida Cardiology Group, PA, Orlando
Florida Cardiovascular Research, Atlantis
Heart Specialists of Sarasota, Sarasota
Ocala Research Institute, Inc, Ocala
The Cleveland Clinic Foundation, Cleveland
The Lindner Clinical Trial Center, Cincinnati
The Care Group, LLC, Indianapolis
Iowa Heart Center, PC, Des Moines
Krankanhaus Duren gem.GmbH, Düren
Medical College of Wisconsin, Milwaukee
Johannes Gutenberg Universitat Mainz, Mainz
Minneapolis Heart Institute Foundation, Minneapolis
Midwest Heart Foundation, Lombard
Rush University Medical Center, Chicago
Loyola University Medical Center, Maywood
Heart Care Midwest, Peoria
Prairie Cardiovascular Consultants, Ltd, Springfield
Kansas Cardiology Associates, Wichita
Hopital Cardiologique Louis Pradel, Bron
University of Oklahoma Health Science Center, Oklahoma City
University of Oklahoma Health Sciences Center, Oklahoma City
Plaza Medical Group, PC, Oklahoma City
Institut de Cardiologie, Paris
MEDVAMC, Houston
Audie Murphy VA Medical Center, San Antonio
Amarillo Heart Clinical Research Institute Inc, Amarillo
Los Angeles Cardiology Associates, Los Angeles
Institut Hospitalier Jacques Cartier, Massy
Anil V. Shah, MD, Santa Ana
UMass Memorial Medical Center, Worcester
Newark Beth Israel Medical Center, Newark
Geisinger Clinic, Danville
Virginia Commonwealth University, Richmond
Foothills Medical Center, Calgary
St. Boniface General Hospital, Winnipeg
Southlake Regional Health Centre, Newmarket
Sunnybrook and Women's College Health Sciences Centre, Toronto
Institut de Cardiologie de Montreal, Montreal
Cardiac Catheterization Laboratories of the CHUM, Montreal
CHUM - Hopital St-Luc, Montreal
Hopital du Sacre-Coeur de Montreal, Montreal
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke
University Hospital St Anna, Brno
General University Hospital, Prague
University Hospital Motol, Prague
Medisch Centrum Alkmarr, Alkmaar
Kerckhoff-Klinik GmbH, Bad Nauheim
Universitatmedizin Berlin, Berlin
Vivantes Klinikum Neukolln, Berlin
Virchow-Klinikum, Universtatsmedizin Berlin, Berlin
Klinikum der Universitat au Koln, Cologne
Klinikum der Johann Wolfgang Goethe-Universitat, Frankfurt
Universitatsklinikum Freiburg, Freiburg im Breisgau
Universitatsklinikum Hamburg - Eppendorf, Hamburg
Klinikum der Friedrich-Schiller-Universitat Jena, Jena
Universitatsklinikum Schleswig-Holstein, Lübeck
Klinik der Universitat Munchen-Grobhadern, München
Klinikum Schwalmstadt der Schwalm-Eder-Kliniken, Schwalmstadt
Segeberger Kliniken GmbH, Segeberg
Amphia Hospital, Breda
Catherine Hospital, Eindhoven
St Antonius Hospital, Nieuwegein
Medisch Centrum Rijnmond-Zuid, Rotterdam
Isala Klinleken, Hospital De Weezenlanden, Zwolle
Middle Slovak Institute of Cardiovascular Diseases, Banská Bystrica
Slovak Institute of Cardiovascular Diseases, Bratislava
Milpark Hospital, Johannesburg
Hospital San Juan de Alicante, Alicante
Hospital Clinic de Barcelona, Barcelona
Hospital Universitari Bellvitge, Barcelona
Lead Sponsor
Sanofi
INDUSTRY